All-cause mortality and hospitalization rates and inpatient expenditures among Medicare fee-for-service beneficiaries decreased from 1999 to 2013.
All-cause mortality and hospitalization rates and inpatient expenditures among Medicare fee-for-service beneficiaries decreased from 1999 to 2013, according to a study published in JAMA.
According to lead author Harlan M. Krumholz, MD, MS, professor of cardiology at the Yale School of Medicine and director of the Yale-New Haven Hospital Center for Outcomes Research and Evaluation, the study’s findings suggest a “remarkable improvement in health and healthcare” in the United States. He attributed this improvement to changes in healthcare technology, delivery, and behaviors.
“The improvements that we observed were extraordinarily broad based,” he explained in an interview with JAMA. “We looked at various different subgroups: we looked by age, we looked by sex, we looked by race. And there was evidence of these improvements everywhere. There still remains some disparities between blacks and whites but both groups experienced this dramatic improvement.”
Dr Krumholz and colleagues examined a sample of 68,374,904 adults age 65 years or older and in Medicare fee-for-service or Medicare Advantage determined all-cause mortality among this population declined from 5.3% in 1999 to 4.5% in 2013. Inpatient expenditures declined from $3290 to $2801 per Medicare fee-for-service beneficiary.
Care for fee-for-service beneficiaries in the last 6 months of life also improved with hospitalizations down from 131 to 103 per 100 deaths and inpatient expenditures decreased from $17,423 in 2009 to $13,388 in 2013.
During the time studied, more patients were being discharged to rehabilitation and nursing facilities or with home healthcare and the proportion of patients discharged to home without care steadily declined.
“Even though it is difficult to disentangle the specific reasons for improvement, it is clear that over the past 15 years there have been marked reductions in mortality, hospitalization, and adverse hospital outcomes among the Medicare population aged 65 years or older,” the authors wrote.
CMS released a final rule to help patients obtain Children’s Health Insurance Program (CHIP) coverage and issued a proposed rule to update Medicare payment policies and rates for inpatient rehabilitation facilities; debate over if gift card incentives are acceptable in health care marketing.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
A global AIDS program that was in limbo for months got temporary relief after congressional negotiators agreed to a 1-year renewal in the next government funding package; the outcome of the November presidential election could determine the state of fetal tissue research in the US; federal officials and industry executives failed to make improvements that stop hacking attacks.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Fragmented Payer System, Vulnerable Supply Chain Among Threats to Accessing Essential Medicines
March 13th 2024During a session of the 2024 V-BID Summit, panelists Stacie Dusetzina, PhD, and Inma Hernandez, PharmD, PhD, discussed how access to essential medications is curtailed not just by the longstanding complexities of insurance design but also by emerging threats such as supply chain weaknesses and cyberattacks.
Read More
Most private health insurers have yet to publish criteria for when they will cover postpartum depression drug, zuranolone; state lawmakers are increasingly opposing health care mergers that they believe do not serve the public interest; Medicaid extensions made in 2021 led to a 40% decline in postpartum lack of insurance.
Read More